Researchers identified a 15-year shift toward surgical de-escalation in gynecologic oncology, marked by fewer surgical ...

Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.

Mastectomy: One or both breasts are removed. Sentinel lymph node biopsy: One or more of the axillary lymph nodes may be ...

Panelists discuss the INSEMA trial, comparing no axillary surgery versus axillary sentinel lymph node biopsy (SLNB) in patients with early invasive breast cancer, exploring the implications for ...

Tom Nolan reviews this week’s research Between 2000 and 2022 the National Institute for Health and Care Excellence (NICE) appraised 332 pharmaceuticals (with 83% getting positive recommendations). Had ...

Key updates from SABCS 2024 in early breast cancer include the COMET study on DCIS recurrence, INSEMA trial on SLNB omission, and OlympiA updates on adjuvant olaparib, shared by Dr Harold Burstein.

Castle Biosciences' TissueCypher test predicts a patient’s risk of progression from Barrett’s oesophagus to oesophageal cancer.

This is called a sentinel lymph node biopsy (SLNB). Your doctor removes the first lymph node or nodes that the melanoma could have spread to. You have a sentinel lymph node biopsy at the same time as ...